was read the article
array:24 [ "pii" => "S1665268119303552" "issn" => "16652681" "doi" => "10.5604/16652681.1226809" "estado" => "S300" "fechaPublicacion" => "2017-01-01" "aid" => "70177" "copyright" => "Fundación Clínica Médica Sur, A.C." "copyrightAnyo" => "2017" "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "edi" "cita" => "Ann Hepatol. 2017;16:8-9" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 83 "formatos" => array:3 [ "EPUB" => 12 "HTML" => 39 "PDF" => 32 ] ] "itemSiguiente" => array:19 [ "pii" => "S1665268119303564" "issn" => "16652681" "doi" => "10.5604/16652681.1226810" "estado" => "S300" "fechaPublicacion" => "2017-01-01" "aid" => "70178" "copyright" => "Fundación Clínica Médica Sur, A.C." "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Ann Hepatol. 2017;16:10-1" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 65 "formatos" => array:3 [ "EPUB" => 12 "HTML" => 28 "PDF" => 25 ] ] "en" => array:10 [ "idiomaDefecto" => true "titulo" => "Right Hepatic Lobe Resection and Thrombocytopenia" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "10" "paginaFinal" => "11" ] ] "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Abimbola Adike, Jorge Rakela, Christopher Czaplicki, Adyr Moss, Elizabeth Carey" "autores" => array:5 [ 0 => array:2 [ "nombre" => "Abimbola" "apellidos" => "Adike" ] 1 => array:2 [ "nombre" => "Jorge" "apellidos" => "Rakela" ] 2 => array:2 [ "nombre" => "Christopher" "apellidos" => "Czaplicki" ] 3 => array:2 [ "nombre" => "Adyr" "apellidos" => "Moss" ] 4 => array:2 [ "nombre" => "Elizabeth" "apellidos" => "Carey" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268119303564?idApp=UINPBA00004N" "url" => "/16652681/0000001600000001/v1_201905311015/S1665268119303564/v1_201905311015/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S1665268119303540" "issn" => "16652681" "doi" => "10.5604/16652681.1226808" "estado" => "S300" "fechaPublicacion" => "2017-01-01" "aid" => "70176" "copyright" => "Fundación Clínica Médica Sur, A.C." "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "edi" "cita" => "Ann Hepatol. 2017;16:6-7" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 109 "formatos" => array:3 [ "EPUB" => 16 "HTML" => 51 "PDF" => 42 ] ] "en" => array:8 [ "idiomaDefecto" => true "titulo" => "Joint Society Statement for elimination of viral hepatitis" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "6" "paginaFinal" => "7" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Javier Brahm, Laurent Castera, Jinlin Hou, Keith Lindor" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Javier" "apellidos" => "Brahm" ] 1 => array:2 [ "nombre" => "Laurent" "apellidos" => "Castera" ] 2 => array:2 [ "nombre" => "Jinlin" "apellidos" => "Hou" ] 3 => array:2 [ "nombre" => "Keith" "apellidos" => "Lindor" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268119303540?idApp=UINPBA00004N" "url" => "/16652681/0000001600000001/v1_201905311015/S1665268119303540/v1_201905311015/en/main.assets" ] "en" => array:11 [ "idiomaDefecto" => true "titulo" => "Ironing out Steatohepatitis" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "8" "paginaFinal" => "9" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "V. Nathan Subramaniam" "autores" => array:1 [ 0 => array:3 [ "nombre" => "V. Nathan" "apellidos" => "Subramaniam" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor1" ] ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Queensland University of Technology (QUT), Brisbane, Queensland, Australia" "identificador" => "aff1" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor1" "etiqueta" => "*" "correspondencia" => "Correspondence and reprint request" ] ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="p0005" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleDisplayedQuote" id="dq0010"><p id="sp0005" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleBold">Article commented</span></p><p id="sp0010" class="elsevierStyleSimplePara elsevierViewall">Handa P, Maliken BD, Nelson JE, Hennessy KA, Vemulakonda LA, Morgan-Stevenson V, Dhillon BK, et al.</p><p id="sp0015" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleBold">Differences in hepatic expression of iron, inflammation and stress-related genes in patients with nonalcoholic steatohepatitis.</span></p><p id="sp0020" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleItalic">Ann Hepatol</span> 2017; 16: 77-85.</p></span></p><p id="p0010" class="elsevierStylePara elsevierViewall">The increasing prevalence of obesity and the metabolic syndrome worldwide is well recognized, the tight association of non-alcoholic fatty liver disease (NAFLD) with these conditions increasingly so. NAFLD can progress to the more severe form of the disorder non-alcoholic stea-tohepatitis (NASH), which is characterized by worsening liver pathology. The prevalence of iron disorders, in particularly the genetic iron overload disorder hereditary he-mochromatosis, is also high in the European population; up to 1:200 individuals carry the at-risk gene variant –the p.C282Y mutation in the <span class="elsevierStyleItalic">HFE</span> gene– which results in significant hepatic iron accumulation.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> A number of studies have examined the association between increased iron levels, the prevalence of <span class="elsevierStyleItalic">HFE</span> mutations and NAFLD/NASH with conflicting results (reviewed recently in reference <a class="elsevierStyleCrossRef" href="#bib0010">2</a>); increased iron has also been proposed as the “second hit” in NAFLD/NASH.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a></p><p id="p0015" class="elsevierStylePara elsevierViewall">In this issue of <span class="elsevierStyleItalic">Annals of Hepatology</span>, Handa, <span class="elsevierStyleItalic">et al.</span><a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> report on the analysis of hepatic gene expression in NAFLD and NASH patients. The authors have a longstanding interest in this field and have continued their work towards understanding the pathophysiology of NAFLD/NASH and the relationship of iron to liver disease. In an attempt to define the genes which may be involved in the progression of NAFLD to NASH they examined the expression of a large number genes involved in the regulation of iron metabolism, inflammation, and oxidative stress in patients with NAFLD and NASH, with or without liver iron accumulation, and correlated this with levels of a number cytokines in serum. Their analysis showed that expression of many genes involved in iron regulation were increased in patients with NASH compared to NAFL; these included <span class="elsevierStyleItalic">HAMP</span> (encoding the iron regulatory hormone hepcidin), <span class="elsevierStyleItalic">TMPRSS6</span> (encoding the negative regulator of hepcidin, transmembrane serine protease 6), <span class="elsevierStyleItalic">STAT3</span> (encoding the cytokine signalling factor, signal transducer and activator of transcription 3). Gene expression of proinflammatory cytokines IL-1β and TNF-α were also increased significantly in livers of NASH patients; while an increase in serum levels of IL-6 and IL-8 was noted. Gene expression of HIF1α (hypoxia inducible factor 1) was significantly reduced in livers of NASH compared to NAFL patients. NAFLD patients with liver iron accumulation also had increased gene expression of <span class="elsevierStyleItalic">HAMP</span> levels; however they had lower cytokine gene expression levels and reduced gene expression of <span class="elsevierStyleItalic">CREBH</span> (the liver-specific cAMP responsive- element binding protein). Based on this data the authors go on to suggest that hepcidin has a regulatory role in the progression from NAFL to NASH in patients. While other studies have previously noted the increase in <span class="elsevierStyleItalic">HAMP</span> in patients with NASH;<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> it is unclear why an increase in <span class="elsevierStyleItalic">TMPRSS6</span> levels is associated with an increase in <span class="elsevierStyleItalic">HAMP</span>, since <span class="elsevierStyleItalic">TMPRSS6</span>, at the protein/enzyme level, cleaves hemojuvelin and thus is a negative regulator of <span class="elsevierStyleItalic">HAMP</span>. Similarly while many studies have examined the response of hepcidin to inflammatory cues, a direct role for hepcidin, as suggested by the authors, in modulating the inflammatory response itself is unclear.</p><p id="p0020" class="elsevierStylePara elsevierViewall">One of the strengths of the study by Handa, <span class="elsevierStyleItalic">et al.</span> is the use of liver biopsies and the significant number available for their analysis; they also examined gene expression of a range of genes involved in iron regulation, inflammation and stress response. Measurements of serum iron, ferritin, transferrin saturation, cytokine levels, markers of inflammation, liver function and cholesterol with a correlation of liver histology and injury provide significant data in this study. However, one of the major limitations of the study, as highlighted by the authors, was the absence of data on serum hepcidin levels, and more importantly <span class="elsevierStyleItalic">HFE</span> geno-typing in the patients; the <span class="elsevierStyleItalic">HFE</span> genotype has been shown to affect both serum and hepatic iron and hepcidin levels. It is unclear if the interpretation of the data would be affected and if so how significantly.<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a> A second aspect is the absence of protein data on some iron regulatory proteins which are post-translationally regulated; these include phosphorylated <span class="elsevierStyleItalic">STAT3</span> which is the mediator of IL-6 regulation of hepcidin and hemojuvelin (<span class="elsevierStyleItalic">HJV</span>, a positive regulator of hepcidin and a substrate for <span class="elsevierStyleItalic">TMPRSS6</span>). However, this may be due to the usual and expected paucity of protein material which is obtained from liver biopsies.</p><p id="p0025" class="elsevierStylePara elsevierViewall">Previous studies have attempted to do examine the hepatic gene expression profiles in NAFLD and NASH; the majority of studies however have been performed in cell lines or in animal models of liver disease. In one recent study the authors concluded that expression of a number genes and variants in these genes may contribute to development of NAFLD.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> In addition recent studies suggest that epigenetics, an inheritable but potentially reversible phenomena which affects expression of genes, may also play a role in this chronic liver disease (reviewed in reference <a class="elsevierStyleCrossRef" href="#bib0040">8</a>).</p><p id="p0030" class="elsevierStylePara elsevierViewall">In conclusion, the study by Handa, <span class="elsevierStyleItalic">et al.</span> has been important in re-examining the role of iron, inflammation and stress in the progression of NAFLD to NASH and the genes involved; it is however apparent that additional systematic and high-powered molecular studies are required to enable a more thorough understanding of this complex and chronic liver disease.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2016-12-18" "fechaAceptado" => "2016-12-18" "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bs0010" "bibliografiaReferencia" => array:8 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Haemochromatosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "Powell L.W." 1 => "Seckington R.C." 2 => "Deugnier Y." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(15)01315-X" "Revista" => array:7 [ "tituloSerie" => "Lancet" "fecha" => "2016" "volumen" => "388" "paginaInicial" => "706" "paginaFinal" => "716" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26975792" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S1474442210703215" "estado" => "S300" "issn" => "14744422" ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Iron and non-alcoholic fatty liver disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "Britton L.J." 1 => "Subramaniam V.N." 2 => "Crawford D.H." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3748/wjg.v22.i36.8112" "Revista" => array:6 [ "tituloSerie" => "World J Gastroenterol" "fecha" => "2016" "volumen" => "22" "paginaInicial" => "8112" "paginaFinal" => "8122" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27688653" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Non-alcoholic fatty liver disease: is iron relevant?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "O’Brien J." 1 => "Powell L.W." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s12072-011-9304-9" "Revista" => array:6 [ "tituloSerie" => "Hepatol Int" "fecha" => "2012" "volumen" => "6" "paginaInicial" => "332" "paginaFinal" => "341" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22020821" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Differences in hepatic expression of iron, inflammation and stress-related genes in patients with non-alcoholic steatohepatitis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:7 [ 0 => "Handa P." 1 => "Maliken B.D." 2 => "Nelson J.E." 3 => "Hennessy K.A." 4 => "Vemulakon-da L.A." 5 => "Morgan-Stevenson V." 6 => "Dhillon B.K." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.5604/16652681.1226818" "Revista" => array:6 [ "tituloSerie" => "Ann Hepatol" "fecha" => "2017" "volumen" => "16" "paginaInicial" => "77" "paginaFinal" => "85" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28051796" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Serum levels of hepcidin in patients with biopsy-proven nonalcoholic fatty liver disease" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:7 [ 0 => "Senates E." 1 => "Yilmaz Y." 2 => "Colak Y." 3 => "Ozturk O." 4 => "Altunoz M.E." 5 => "Kurt R." 6 => "Ozkara S." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1089/met.2010.0121" "Revista" => array:6 [ "tituloSerie" => "Metab Syndr Relat Disord" "fecha" => "2011" "volumen" => "9" "paginaInicial" => "287" "paginaFinal" => "290" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21417913" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "Bonkovsky H.L." 1 => "Jawaid Q." 2 => "Tortorelli K." 3 => "LeClair P." 4 => "Cobb J." 5 => "Lambrecht R.W." 6 => "Banner B.F." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "HFE gene in non-alcoholic steatohepatitis. J Hepatol" "fecha" => "1999" "volumen" => "31" "paginaInicial" => "421" "paginaFinal" => "429" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10488699" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Genetic factors that affect non-alcoholic fatty liver disease: A systematic clinical review" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "Severson T.J." 1 => "Besur S." 2 => "Bonkovsky H.L." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3748/wjg.v22.i29.6742" "Revista" => array:6 [ "tituloSerie" => "World J Gastroenterol" "fecha" => "2016" "volumen" => "22" "paginaInicial" => "6742" "paginaFinal" => "6756" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27547017" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Epigenetics in non-alcoholic fatty liver disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "Lee J." 1 => "Kim Y." 2 => "Friso S." 3 => "Choi S.W." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:2 [ "titulo" => "Mol Aspects Med" "serieFecha" => "2016" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/16652681/0000001600000001/v1_201905311015/S1665268119303552/v1_201905311015/en/main.assets" "Apartado" => array:4 [ "identificador" => "77716" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Editorial" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/16652681/0000001600000001/v1_201905311015/S1665268119303552/v1_201905311015/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268119303552?idApp=UINPBA00004N" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 6 | 0 | 6 |
2024 October | 18 | 1 | 19 |
2024 September | 16 | 1 | 17 |
2024 August | 12 | 3 | 15 |
2024 July | 9 | 0 | 9 |
2024 June | 10 | 2 | 12 |
2024 May | 9 | 4 | 13 |
2024 April | 10 | 3 | 13 |
2024 March | 9 | 6 | 15 |
2024 February | 3 | 5 | 8 |
2024 January | 4 | 1 | 5 |
2023 December | 5 | 4 | 9 |
2023 November | 8 | 2 | 10 |
2023 October | 10 | 7 | 17 |
2023 September | 7 | 0 | 7 |
2023 August | 8 | 3 | 11 |
2023 July | 5 | 4 | 9 |
2023 June | 2 | 0 | 2 |
2023 May | 4 | 3 | 7 |
2023 April | 3 | 3 | 6 |
2023 March | 4 | 5 | 9 |
2023 February | 3 | 3 | 6 |
2023 January | 5 | 6 | 11 |
2022 December | 5 | 2 | 7 |
2022 November | 4 | 5 | 9 |
2022 October | 5 | 7 | 12 |
2022 September | 8 | 5 | 13 |
2022 August | 5 | 4 | 9 |
2022 July | 10 | 8 | 18 |
2022 June | 5 | 8 | 13 |
2022 May | 4 | 5 | 9 |
2022 April | 7 | 8 | 15 |
2022 March | 6 | 8 | 14 |
2022 February | 7 | 9 | 16 |
2022 January | 12 | 4 | 16 |
2021 December | 6 | 9 | 15 |
2021 November | 7 | 2 | 9 |
2021 October | 7 | 5 | 12 |
2021 September | 6 | 9 | 15 |
2021 August | 5 | 6 | 11 |
2021 July | 7 | 12 | 19 |
2021 June | 9 | 9 | 18 |
2021 May | 9 | 5 | 14 |
2021 April | 22 | 5 | 27 |
2021 March | 9 | 9 | 18 |
2021 February | 6 | 5 | 11 |
2021 January | 2 | 8 | 10 |
2020 December | 5 | 4 | 9 |
2020 November | 6 | 5 | 11 |
2020 October | 11 | 6 | 17 |
2020 September | 11 | 5 | 16 |
2020 August | 6 | 9 | 15 |
2020 July | 6 | 5 | 11 |
2020 June | 5 | 8 | 13 |
2020 May | 5 | 4 | 9 |
2020 April | 5 | 3 | 8 |
2020 March | 4 | 2 | 6 |
2020 February | 4 | 3 | 7 |
2020 January | 5 | 2 | 7 |
2019 December | 9 | 6 | 15 |
2019 November | 5 | 1 | 6 |
2019 October | 2 | 0 | 2 |
2019 September | 1 | 2 | 3 |
2019 August | 1 | 1 | 2 |
2019 July | 5 | 6 | 11 |
2019 June | 8 | 7 | 15 |
2019 May | 2 | 4 | 6 |